17 November 2004
Aromatase inhibitors, Oestrogen receptor blockers, Growth hormone, Growth hormone deficiency, Central precocious puberty, Gonadotropin-releasing hormone analogues, Puberty, Idiopathic short stature, Spontaneous puberty, Congenital adrenal hyperplasia
Short stature in adulthood can be considered as a disability because it can be associated with many difficulties including those of a psychological and social nature. Many factors can influence final adult height such as genetics, the magnitude of growth hormone (GH) secretion, height before puberty, and the onset and duration of puberty. A crucial factor affecting final adult height, however, is the total height achieved during puberty. The combination of GH and gonadotropin-releasing hormone analogues greatly enhances growth and their separate and combined use for the treatment of GH deficiency, central precocious puberty and other diagnoses in children and adolescents is discussed in this article.